Close

Morning Movers 03/06: (HNR) (XOMA) (MDSO) (SHFL) Higher; (ONTY) (ZLTQ) (DATE) (SMP) Lower

March 6, 2012 10:46 AM EST
Oncothyreon, Inc. (NASDAQ: ONTY) 34% LOWER; reported Q4 EPS of ($0.27), $0.12 worse than the analyst estimate of ($0.15). Expenses in 2012 are expected to be higher when compared to 2011, primarily as a result of the more advanced clinical development of PX-866 and the Phase 1 clinical trial of ONT-10. Oncothyreon currently expects cash used in operations in 2012 to be between approximately $30.0 and approximately $33.0 million. As a result, Oncothyreon estimates that its existing cash, cash-equivalents and investments will be sufficient to fund operations for at least the next 12 months.

ZELTIQ Aesthetics (NASDAQ: ZLTQ) 32% LOWER; reported Q4 EPS of ($0.22), $0.13 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $22 million. Sees FY2012 revenue of $90-$94 million, versus the consensus of $113.9 million.

Harvest Natural Resources, Inc. (NYSE: HNR) 30.8% HIGHER; revising 2011 financial statements for errors: the cumulative net adjustment increases net income by about $3 million. The company said it is currently in talks on its Petrodelta unit. The stock was upgraded at Pritchard earlier.

Xoma (Nasdaq: XOMA) 27.2% HIGHER; prices 29.7 million shares at $1.32/share.

Jiayuan.com (NASDAQ: DATE) 19.1% LOWER; reported Q4 non-GAAP EPS of $0.01, $0.05 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $14.39 million. Jiayuan currently expects to generate net revenues in the range of RMB90 million to RMB92 million for the first quarter of 2012.

Standard Motor Products (NYSE: SMP) 17.5% LOWER; reported Q4 EPS of $0.17, $0.03 better than the analyst estimate of $0.14. Revenue for the quarter came in at $174.2 million versus the consensus estimate of $182.31 million. Sees first quarter 2012 sales flat to slightly below 2011 first quarter results.

Medidata Solutions, Inc. (NASDAQ: MDSO) 15.7% HIGHER; reported Q4 EPS of $0.37, in-line with the analyst estimate of $0.37. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $47.14 million. Sees FY2012 revenue of $210-$215 million, versus the consensus of $205.10 million. Sees Q1 2012 revenue of $48.5-$49.5 million, versus the consensus of $47.90 million.

Shuffle Master, Inc. (NASDAQ: SHFL) 14% HIGHER; reported Q1 EPS of $0.09, $0.02 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $51.11 million. The company entered into a definitive agreement to acquire Ongame Network Ltd., from bwin.party Services (Austria) GmbH.

Keryx Biopharma (Nasdaq: KERX) 14% LOWER; biotech stocks Keryx and AEterna Zentaris are both lower Tuesday as there is now questions about analysis of the recent Seeking Alpha article which said FDA approval is "practically a done deal". Click here to see the full report.

US Home Systems (Nasdaq: USHS) 13.9% LOWER; continuing a volatile stretch which kicked off about three weeks ago. Shares rose nearly 21 percent over Monday through Thursday of last week, only to sell off by nearly 24 percent on Friday. Shares retook gains yesterday (up about 8 percent) and are continuing below the $11 level today. Volume remains very heavy.

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) 12.9% HIGHER; reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.

AEterna Zentaris (Nasdaq: AEZS) 11.6% LOWER; see above.

Galena Biopharma (Nasdaq: GALE) 11.3% LOWER; shares have been extremely volatile lately: the stock rose more than 19 percent on Thursday of last week, another 13 percent Friday, and then nearly 16 percent yesterday. The stock has broken below the 200-day SMA today.

Monster Worldwide, Inc. (NYSE: MWW) 9.7% HIGHER; today announced that it has retained Stone Key Partners LLC and BofA Merrill Lynch as financial advisors in connection with its review of strategic alternatives, which was previously announced by the Company on March 1, 2012. Evercore upgraded the stock to Overweight earlier.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Morning Movers